TICKERS: KRYS

Krystal Biotech Inc. (KRYS:NASDAQ) --- Placeholder

Source: Streetwise Reports (11/29/21)

aaaa

NRx Pharma's COVID-19 Vaccine Displays Effectiveness Against Delta Variant in Phase 2 Clinical Trial
Source: Streetwise Reports (11/29/2021)

Shares of NRx Pharmaceuticals Inc. traded 50% higher after the company commented on new data released by the Israel Institute for Biological Research regarding the effectiveness of its BriLife® COVID-19 Vaccine against the SARS-CoV-2 "Delta" variant.

Shares of Longeveron Inc. traded 50% higher after the company reported that the U.S. FDA approved its Lomecel-B for Rare Pediatric Disease Designation to treat a rare and life-threatening defect in infants called Hypoplastic Left Heart Syndrome.

RNA Silencing Platform Firm Receives US$3.3 Billion Buyout Offer From Novo Nordisk
Source: Streetwise Reports (11/18/2021)

Shares of Dicerna Pharmaceuticals Inc. traded 78% higher after the company reported it entered into a definitive agreement to be acquired by Novo Nordisk A/S of Denmark for $38.25 per share in cash.

Novavax Submits Request to EMA for Conditional Marketing Authorization for COVID-19 Vaccine
Source: Streetwise Reports (11/17/2021)

Shares of Novavax Inc. traded 10% higher after the firm confirmed that the European Medicines Agency is now reviewing its COVID-19 vaccine filing for conditional marketing authorization. The firm advised that an opinion from the agency is expected within a few weeks.

Biotech Co.'s Shares Gain 32% After Posting Meaningful Renal Response Rates in Ph. 2 Lupus Study
Source: Streetwise Reports (11/16/2021)

Shares of Kezar Life Sciences Inc. rose to a new 52-week high after the company reported promising interim results from its Phase 2 trial of KZR-616 in patients with lupus nephritis.